title: Neuroprotective effect of oxaloacetate in a focal brain ischemic model in the rat.
abstract: During an ischemic event, the well-regulated glutamate (Glu) homeostasis is disturbed, which gives rise to extremely high levels of this excitatory neurotransmitter in the brain tissues. It was earlier reported that the administration of oxaloacetate (OxAc) as a Glu scavenger reduces the Glu level in the brain by enhancing the brain-to-blood Glu efflux. Here, we studied the neuroprotective effect of OxAc administration in a new focal ischemic model in rats. Occlusion of the middle cerebral artery resulted in immediate reduction of the somatosensory-evoked responses (SERs), and the amplitudes remained at the reduced level throughout the whole ischemic period. On reperfusion, the SERs started to increase, but never reached the control level. OxAc proved to be protective, since the amplitudes started to recover even during the ischemia, and finally fully regained the control level. The findings of the histological measurements were in accordance with the electrophysiological data. After Fluoro Jade C staining, significantly fewer labeled cells were detected in the OxAc-treated group relative to the control. These results provide new evidence of the neuroprotective effect of OxAc against ischemic injury, which strengthens the likelihood of its future applicability as a novel neuroprotective agent for the treatment of ischemic stroke patients.
authors.affiliation: Department of Physiology, Anatomy and Neuroscience, University of Szeged, Közép fasor 52, Szeged, H-6726, Hungary.
authors.forename: L
authors.initials: L
authors.lastname: Knapp
authors.forename: L
authors.initials: L
authors.lastname: Gellért
authors.forename: K
authors.initials: K
authors.lastname: Kocsis
authors.forename: Z
authors.initials: Z
authors.lastname: Kis
authors.forename: T
authors.initials: T
authors.lastname: Farkas
authors.forename: L
authors.initials: L
authors.lastname: Vécsei
authors.forename: J
authors.initials: J
authors.lastname: Toldi
mesh_terms: D000818:Animals; D002545:Brain Ischemia / Q000473:pathology* / Q000517:prevention & control*; D004195:Disease Models, Animal; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D062907:Oxaloacetic Acid / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D016896:Treatment Outcome
chemical_list: D018696:Neuroprotective Agents; D062907:Oxaloacetic Acid